- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 15.3243 ↑ 0.15%
[as on 30 April, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of quant Healthcare Fund - Growth Option - Regular Plan and its peers as on 30 April, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 30.19% | -6.4% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|
| Returns | -2.56% | -0.27% | 0.12% | 1.13% | -0.63% | -1.91% | -5.2% | 2.44% | -5.47% | 6.1% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | -5.78% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 84.62% |
6.69% (Arbitrage: 0.00%) |
0.00% |
0.00% |
-6.64% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| SMS Pharmaceuticals Limited | SMSPHARMA (INE812G01025) | Pharmaceuticals & Biotechnology | 10.42% |
| ANTHEM BIOSCIENCES LIMITED | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 9.29% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 9.16% |
| Zydus Wellness Ltd | ZYDUSWELL (INE768C01028) | Food Products | 8.38% |
| Sequent Scientific Limited | SEQUENT (INE807F01027) | Pharmaceuticals & Biotechnology | 8.33% |
| Alivus Life Sciences | ALIVUS (INE03Q201024) | Pharmaceuticals & Biotechnology | 7.33% |
| Pfizer Ltd | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 6.93% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 5.20% |
| ICICI Prudential Life Insurance Co Ltd | ICICIPRULI (INE726G01019) | Insurance | 4.64% |
| HDFC Life Insurance Co Ltd | HDFCLIFE (INE795G01014) | Insurance | 4.12% |
| Medplus Health Services Limited | MEDPLUS (INE804L01022) | Retailing | 3.86% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 2.60% |
| Glaxosmithkline Pharmaceuticals Ltd | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 2.27% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.46% |
| Adani Enterprises Limited | ADANIENT (INE423A01024) | Metals & Minerals Trading | 0.61% |
Debt
| Name | Rating | Weight % |
|---|
| 91 Days Treasury Bill 22-May-2026 | N.A. | 1.82% |
| 91 Days Treasury Bill 23-Apr-2026 | N.A. | 0.92% |
| 91 Days Treasury Bill 30-Apr-2026 | N.A. | 0.91% |
| 91 Days Treasury Bill 07-May-2026 | N.A. | 0.91% |
| 91 Days Treasury Bill 14-May-2026 | N.A. | 0.91% |
| 91 Days Treasury Bill 04-Jun-2026 | N.A. | 0.91% |
| 91 Days Treasury Bill 17-Apr-2026 | N.A. | 0.31% |
Portfolio data is as on date 31 March, 2026
NAV history
quant Healthcare Fund - Growth Option - Regular Plan - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 30 April, 2026 | 15.3243 | 0.15% |
| 29 April, 2026 | 15.3019 | 0.22% |
| 28 April, 2026 | 15.2689 | -0.7% |
| 27 April, 2026 | 15.3773 | 1.33% |
| 24 April, 2026 | 15.1761 | -1.2% |
| 23 April, 2026 | 15.3612 | -0.33% |
| 22 April, 2026 | 15.4127 | 0.59% |
| 21 April, 2026 | 15.323 | 0.54% |
| 20 April, 2026 | 15.2405 | -0.89% |
| 17 April, 2026 | 15.3773 | 0.54% |
| 16 April, 2026 | 15.2941 | -0.86% |
| 15 April, 2026 | 15.4269 | 1.76% |
| 13 April, 2026 | 15.1595 | -0.04% |
| 10 April, 2026 | 15.1662 | 1.34% |
| 9 April, 2026 | 14.9655 | 0.66% |
| 8 April, 2026 | 14.8669 | 1.96% |
| 7 April, 2026 | 14.5815 | -0.45% |
| 6 April, 2026 | 14.6467 | 2.19% |
| 2 April, 2026 | 14.3334 | -0.76% |
| 1 April, 2026 | 14.4438 | 1.9% |
| 31 March, 2026 | 14.1748 | 0% |
| 30 March, 2026 | 14.1754 | -1.93% |
| 27 March, 2026 | 14.4544 | -0.78% |
| 25 March, 2026 | 14.5684 | 1.95% |
| 24 March, 2026 | 14.2895 | 2.9% |
| 23 March, 2026 | 13.8869 | -3.1% |
| 20 March, 2026 | 14.3307 | 1.15% |
| 19 March, 2026 | 14.1677 | -2.86% |
| 18 March, 2026 | 14.5848 | 0.8% |
| 17 March, 2026 | 14.4689 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Regular Plan?
The latest NAV of quant Healthcare Fund - Growth Option - Regular Plan is 15.3243 as on 30 April, 2026.
What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Regular Plan?
The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Regular Plan are 2.43% as on 30 April, 2026.
What are 1 year returns of quant Healthcare Fund - Growth Option - Regular Plan?
The 1 year returns of quant Healthcare Fund - Growth Option - Regular Plan are 4.88% as on 30 April, 2026.